28 March 2023 :Aker BioMarine ASA today publishes its Annual Report for 2022, which includes the annual accounts, the report on ESG (Environmental, Social and Governance) and the auditor's report for 2022. The report is attached and is also available at www.akerbiomarine.com.Aker BioMarine ASA has also published its annual financial statements in European Single Electronic Format (ESEF), available as an attachment to this release. For further information, please contactKatrine Klaveness , CFO Mobile: +47 991 58 915 Email: Katrine.Klaveness@akerbiomarine.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. AboutAker BioMarine Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters ofAntarctica .Aker BioMarine is listed onOslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Click here for more information
© Oslo Bors ASA, source